Atlas Trials

Study to Assess Effectiveness of Therapy Timely Adjustment Based on Self-monitoring in Patients Suffering From Mild-to-moderate Ulcerative Colitis (OPTIMISE Study)

Clinical trial NCT04340895 · COMPLETED

Trial details

NCT number
NCT04340895
Sponsor
Ferring Pharmaceuticals
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Mild-to-moderate Ulcerative Colitis
Start date
2019-10-14
Primary completion
2023-10-20
Enrollment
250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.